Home
Careers
Conferences
Directory
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
«
Zoonoses
Below is an extended Zoonoses patents listing.
Click here to return to the Zoonoses main in depth entry.
Patents :
US Patent No.
Title
4267170
Methods of using chlamydia vaccine for preventing and treating bovine diseases
5510241
Method of testing for the presence of Salmonella serotypes expressing Salmonella enteritidis fimbrial antigen (SEFA) and reagents therefore
5616689
Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation
5716822
Feline calicivirus capsid gene and protein
5718901
Feline calicivirus gene
5730984
Vaccine against helminth infection comprising Sm-14 fatty acid binding protein of Schistosoma mansoni
5756678
Prion inactivation in connective tissue materials
5795779
Human interferon-.beta. (IFN-.beta.) produced in Chinese hamster ovary (CHO) cells
5879719
Process for control, elimination or inhibition of salmonellae in reptiles and/or amphibians
5464625
Non-toxic methods of repelling rodents from materials susceptible to rodent consumption
5376567
Expression of interferon genes in Chinese hamster ovary cells
5202430
Transmissible gastroenteritis virus genes
4569908
Multiclass hybrid interferons
4758428
Multiclass hybrid interferons
4966843
Expression of interferon genes in Chinese hamster ovary cells
4973479
Interferon-.alpha.61
4975276
Interferon-alpha 54
5019411
Process for bacterial decontamination of vegetable foods
5098703
Interferon-alpha 76
5178857
Pharmaceutical compositions and their use in the treatment of parasitoses
6039684
Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome
6191168
Methods for the use of nonprotein amino acids as therapeutic agents
6444445
Live vaccine against Brucellosis
7128916
Bacteriophage-mediated immunisation
7148323
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
7235232
Interferon alpha hybrids
7311904
Tissue matrices comprising placental stem cells, and methods of making the same
7364745
Development of a live, attenuated, recombinant vaccine for Brucellosis
7390626
Methods and kit for diagnosing tick borne illnesses
7404969
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7410474
Methods and means for extracorporeal organ perfusion
7101554
Picornaviruses, vaccines and diagnostic kits
7041444
Murine calicivirus
6986887
Universal stem cells
6518064
Pink bollworm expression system for commercially valuable protein production
6554188
Terminal for an active labelling system
6593080
Diagnosis, prevention and treatment of calicivirus infection in humans
6685933
Interferon .alpha. hybrids
6743899
Process for inactivating prions in lipoproteins
6825028
Recombinant listeria
6930176
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
6943239
Antigenic fusionprotein carrying Gal.alpha.1,3Gal epitopes
7427398
Mammalian animal composition
Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
About BioPortfolio
User Agreements
Post News
Post Events
Post Jobs
Post Company Profile
Advertising
News feeds RSS
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.